Filed: 2/12/2024ACC: 0001910264-24-000001
📋 What this filing means
SR ONE CAPITAL MANAGEMENT, LP filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $238.16M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$238.16M
Total AUM (reported)
16.81M
Total Shares
Allocation by class
COMMON STOCK$174.64M73.3%
COM$63.52M26.7%
Portfolio Concentration
Top 3$213.92M89.8%
4–10$24.23M10.2%
Top 3 weight
89.8%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 16.81M
Sole
Full voting authority
16.81M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
ARCELLX INC.
SOLEShares3.15M
TypeSH
Market value$174.64M
73.33%
Sole
3.15M
Shared
0.00
None
0.00
ARS PHARMACEUTICALS
SOLEShares4.01M
TypeSH
Market value$21.99M
9.23%
Sole
4.01M
Shared
0.00
None
0.00
DESIGN THERAPEUTICS INC
SOLEShares6.53M
TypeSH
Market value$17.30M
7.26%
Sole
6.53M
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS
SOLEShares1.79M
TypeSH
Market value$15.43M
6.48%
Sole
1.79M
Shared
0.00
None
0.00
NKARTA INC.
SOLEShares1.33M
TypeSH
Market value$8.80M
3.70%
Sole
1.33M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ARCELLX INC.SOLE | COMMON STOCK | 3.15M | SH | $174.64M 73.33% | 3.15M | 0.00 | 0.00 |
ARS PHARMACEUTICALSSOLE | COM | 4.01M | SH | $21.99M 9.23% | 4.01M | 0.00 | 0.00 |
DESIGN THERAPEUTICS INCSOLE | COM | 6.53M | SH | $17.30M 7.26% | 6.53M | 0.00 | 0.00 |
MINERALYS THERAPEUTICSSOLE | COM | 1.79M | SH | $15.43M 6.48% | 1.79M | 0.00 | 0.00 |
NKARTA INC.SOLE | COM | 1.33M | SH | $8.80M 3.70% | 1.33M | 0.00 | 0.00 |